Harrow, Inc.
HROW
#5444
Rank
NZ$2.33 B
Marketcap
NZ$62.81
Share price
1.44%
Change (1 day)
44.00%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2025 (TTM): NZ$33.49 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are NZ$0.25 Billion. In 2024 the company made an earning of NZ$9.55 Million, an increase over its 2023 earnings that were of -NZ$4.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$33.49 M250.67%
2024 NZ$9.55 M-329.09%
2023 -NZ$4.17 Million-224.34%
2022 NZ$3.35 M3.01%
2021 NZ$3.25 M149.06%
2020 NZ$1.3 M434.29%
2019 NZ$0.24 M-102.68%
2018 -NZ$9.12 Million-57.11%
2017 -NZ$21.26 Million-21.93%
2016 -NZ$27.23 Million5.11%
2015 -NZ$25.91 Million46.16%
2014 -NZ$17.73 Million32.68%
2013 -NZ$13.36 Million42.63%
2012 -NZ$9.37 Million
2010 -NZ$4.33 Million-45.76%
2009 -NZ$7.98 Million21.83%
2008 -NZ$6.55 Million-491.97%
2007 NZ$1.67 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.28 Billion-902.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.73 Million-191.39%๐Ÿ‡บ๐Ÿ‡ธ USA